REMISOL ADVANCE
Report
- Report Number
- 3006543086-2018-01000
- Event Type
- Injury
- Date Received
- October 9, 2018
- Date of Event
- June 29, 2018
- Report Date
- September 10, 2018
- Manufacturer
- NORMAND-INFO S.A.S.U.
- Product Code
- JQP
- UDI-DI
- 13700962600938
- PMA / PMN Number
- EXEMPT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
NORMAND TECHNICAL SUPPORT AND AN INFORMATICS TECHNICAL SPECIALIST REVIEWED THE ISSUE, AND OBSERVED THE AUTO-VALIDATION STOPPING COMMENT LINKED TO FERRITIN WAS REMOVED WHEN THE RESULT WAS DELETED. THEN WHEN THE SAMPLE WAS RERUN, THIS COMMENT WAS NOT RECREATED BECAUSE THE RULE THAT GENERATED IT WAS CONFIGURED TO PLAY ONCE. THIS LED TO THE FERRITIN RESULT BEING AUTO-VALIDATED AS THE AUTO-VALIDATION RULE WAS UNABLE TO FIND THE MISSING COMMENT. THE CAUSE OF THE ISSUE IS ATTRIBUTED TO USE ERROR DUE TO AN INCORRECT RULE AND THE CUSTOMER DELETING A RESULT. THE ISSUE WAS RESOLVED BY MODIFYING THE RULE IN REMISOL AND DISCUSSING THE CORRECT MANAGEMENT OF THE FAILURE AND RESULTS WITH THE CUSTOMER. (B)(4).
THE CUSTOMER REPORTED THEIR REMISOL AUTO-VALIDATED AN ERRONEOUS PATIENT RESULT FOR FERRITIN. THE ERRONEOUS RESULT WAS AUTO-RELEASED OUT OF THE LABORATORY. THE PHYSICIAN STOPPED TREATMENT FOR A PATIENT BASED ON THE ERRONEOUS RESULT. PATIENT TREATMENT WAS RESUMED UPON NOTIFICATION OF THE ISSUE. NO SPECIFIC DETAILS OF THE PATIENT TREATMENT WERE PROVIDED. THERE WAS NO REPORT OF HARM TO THE PATIENT. NO DETAILS WERE PROVIDED IN REGARDS TO THE INSTRUMENT USED TO RUN THE PATIENT SAMPLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 786952 | REMISOL ADVANCE | REMISOL ADVANCE | JQP | NORMAND-INFO S.A.S.U. | NA | NA | 13700962600938 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 47 YR | Other |